Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations
Clinical trial NCT07195695 · RECRUITING
Trial details
- NCT number
- NCT07195695
- Sponsor
- Boehringer Ingelheim
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-16
- Primary completion
- 2032-02-26
- Enrollment
- 400
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.